Dental Care Clinics in Abbeville, LA Accepting Medicare
6 Dental Care Clinics found. Showing 1 - 6
 Gerald A Baudin Ii D D S A Professional Corporation Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2623 South Dr, Abbeville, LA 70510 Phone: 337-893-6033 Fax: 337-893-6074 |
Abbeville Family Dental Dentist Medicare: Not Enrolled in Medicare Practice Location: 2617 South Dr, Abbeville, LA 70510 Phone: 337-893-2614 Fax: 337-893-4662 |
Chuck C Soileau, Dds, Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 201 S Saint Charles St, Abbeville, LA 70510 Phone: 337-893-1521 |
Vermilion General Dentistry Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2617 South Dr, Abbeville, LA 70510 Phone: 337-893-2614 Fax: 337-893-4662 |
John L. Robert, Jr. D.d.s., A Professional Dental Corporation Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2616 North Dr, Abbeville, LA 70510 Phone: 337-893-8048 Fax: 337-893-8048 |
Dr Gerald Baudin Dds A Dental Corporation Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2623 South Drive, Abbeville, LA 70510 Phone: 337-893-6033 Fax: 337-893-6074 |
News Archive
DUSA Pharmaceuticals receives notice of allowance for patent covering blue light technology
DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), today announced that the United States Patent and Trademark Office has issued a notice of allowance for a key patent related to its proprietary PDT light source, the BLU-U®, Blue Light Photodynamic Therapy Illuminator.
Omeros announces positive data from OMS824 Phase 1 clinical trial
Omeros Corporation today announced positive data from the Company's Phase 1 clinical trial evaluating the pharmacokinetics of OMS824, the lead compound in Omeros' phosphodiesterase 10 program, further supporting that OMS824 can achieve superior target engagement with lesser side effects compared to other PDE10 inhibitors in development.
NIH panel recommends delivery options for women: VBAC or cesarean
An independent panel convened this week by the National Institutes of Health confronted a troubling fact that pregnant women currently have limited access to clinicians and facilities able and willing to offer a trial of labor after previous cesarean delivery because of so-called VBAC bans.
Top scientist says alcohol guidelines should be changed
The latest research on the health effects of drinking alcohol has found that drinking moderate amounts of alcohol has a significant benefit - wait for it - for people with an unhealthy lifestyle!
α1-adrenoceptor blockade improves nocturia and sleep quality
Treatment with an α1-adrenoceptor antagonist drug is associated with significant improvements in nocturia, sleep quality and lower urinary tract symptoms in women with voiding symptoms, study findings show.
› Verified 9 days ago